Co-Diagnostics logo

Co-Diagnostics

CODX | NASDAQ
Chart Builder DCF Calculator
$0.47
-$0.08 (-14.12%)
At close: Oct 27, 2026, 4:00 PM ET
-14.12%

Rating

Updated: Oct 21, 2026
31.8
-1.4 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $3.27M
1D Range
0.45 0.56
52W Range
0.45 37.80

Valuation (TTM)

PE -0.02
PB 0.26
EV/EBITDA -0.03

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $180.00
Loading financial charts...

Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei...

Sector Healthcare
Industry Biotechnology
Employees 115
IPO Date Jul 12, 2017
Website co-dx.com
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$180.00
Upside
+38197.87%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.